Ranbaxy announced a co-marketing agreement with Ferring International of Switzerland for the latters hormone tablet, Desmopressin, in India.A Ranbaxy statement said the arrangement aims to leverage the companys significant marketing and distribution strengths to maximise patient coverage in the country.The product will be sold under the brand name,Adiuretin.Desmopressin is indicated for treatment of Nocturia,a condition comonly seen in pediatric and geriatric patients. |
